相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition
Marcel Kool et al.
CANCER CELL (2014)
DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies
Edward C. Schwalbe et al.
ACTA NEUROPATHOLOGICA (2013)
Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays
Volker Hovestadt et al.
ACTA NEUROPATHOLOGICA (2013)
Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma
Nataliya Zhukova et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Molecular subgroups of medulloblastoma: the current consensus
Michael D. Taylor et al.
ACTA NEUROPATHOLOGICA (2012)
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
Marcel Kool et al.
ACTA NEUROPATHOLOGICA (2012)
Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations
Tobias Rausch et al.
CELL (2012)
Outcome of Children With Metastatic Medulloblastoma Treated With Carboplatin During Craniospinal Radiotherapy: A Children's Oncology Group Phase I/II Study
Regina I. Jakacki et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Dissecting the genomic complexity underlying medulloblastoma
David T. W. Jones et al.
NATURE (2012)
Medulloblastomics: the end of the beginning
Paul A. Northcott et al.
NATURE REVIEWS CANCER (2012)
Adult Medulloblastoma Comprises Three Major Molecular Variants
Marc Remke et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical Outcome
Yoon-Jae Cho et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Medulloblastoma Comprises Four Distinct Molecular Variants
Paul A. Northcott et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Adult and Pediatric Medulloblastomas Are Genetically Distinct and Require Different Algorithms for Molecular Risk Stratification
Andrey Korshunov et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
TP53 Mutation Is Frequently Associated With CTNNB1 Mutation or MYCN Amplification and Is Compatible With Long-Term Survival in Medulloblastoma
Elke Pfaff et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Medulloblastoma Variants: Age-Dependent Occurrence and Relation to Gorlin Syndrome-A New Clinical Perspective
Maria Luisa Garre et al.
CLINICAL CANCER RESEARCH (2009)
Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91
Katja von Hoff et al.
EUROPEAN JOURNAL OF CANCER (2009)
Outcome Prediction in Pediatric Medulloblastoma Based on DNA Copy-Number Aberrations of Chromosomes 6q and 17q and the MYC and MYCN Loci
Stefan Pfister et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features
Marcel Kool et al.
PLOS ONE (2008)
Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas
Arend Koch et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis
Steven C. Clifford et al.
CELL CYCLE (2006)
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial
Amar Gajjar et al.
LANCET ONCOLOGY (2006)
Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma
Roger J. Packer et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Genornics identifies medulloblastoma subgroups that are enriched for specific genetic alterations
MC Thompson et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
β-catenin status predicts a favorable outcome in childhood medulloblastoma:: The United Kingdom Children's Cancer Study Group Brain Tumour Committee
DW Ellison et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Treatment of early childhood medulloblastoma by postoperative chemotherapy alone
S Rutkowski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Mutations in SUFU predispose to medulloblastoma
MD Taylor et al.
NATURE GENETICS (2002)
Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification
JP Schouten et al.
NUCLEIC ACIDS RESEARCH (2002)
Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors
A Koch et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
分享论文
